- Open Access
Research in critically ill patients: standards of informed consent
© BioMed Central Ltd 2007
- Published: 15 February 2007
Patients in critical care lose their capability to make a judgement, and constitute a 'vulnerable population' needing special and reinforced protection. Even if the standard of informed consent is an essential way of demonstrating respect for the patient's autonomy, the usual informed-consent procedure is not as applicable as required or sufficient to warrant this ethical principle in critical care.
- Critical Care
- Glasgow Coma Scale
- Critical Care Setting
- Ethical Role
- Emergency Research
The evolution of ethics recommendations in medical research is the result of past history. After each dramatic event that occurred in the context of medical research, the medical community and lawyers reacted by editing standards. These actions allowed defining the conduct that the researchers must follow in order to ensure the respect for human rights. In a recent review article, Huang and Hadian report current controversies regarding ethical standards of research . One of the relevant questions raised about the need for more standards in ethical research addresses the specific issue of informed consent in critical care.
Because of their acute illness and the special environment, critically ill patients may be temporarily incapacitated. The critically ill lose their capability to understand and to make a judgement, and they therefore constitute a 'vulnerable population' needing special and reinforced protection . The participation of critically ill patients in medical research is particularly important for the community, who will benefit from the ensuing improvement of care in vital situations. In most cases this patient does not benefit from their study participation but endorses the risks. The investigator has the responsibility to protect the patient and to conduct the study according to ethical standards. In order to do so, the investigator should have at their disposal some tools to distinguish competent and incompetent patients. The difficulty is that no objective criterion regarding the decision-making capacity of patients is defined in international and national directives. Investigators usually use their clinical judgement and the Glasgow Coma Scale as guidance. If we had to revise the currently available standards, the definition of the patients' capacity should be a priority.
Informed consent is considered an essential way of protecting the patient and respecting their autonomy. Informed consent, however, is not sufficient to make a clinical research ethical. The informed-consent procedure must fulfil three conditions: adequate information about the study with a complete disclosure of the risks and benefits, the patient's comprehension, and the voluntary nature . Given at the very beginning of a study, informed consent cannot ensure the protection of the patient throughout the whole study by itself. Indeed, we have shown that even when the mandatory conditions were fulfilled and patients were given a valid informed consent for a study, most of them were unable to recall the study components 10 days after the consent procedure [4, 5]. Since the study was ongoing, patients could not use their right to withdraw from the study at any time. We suggested that reconsidering the informed-consent procedure repeatedly during an ongoing study could be useful in order to respect the patient's rights. The ethical role of the investigator does not end at the signature of the consent document but continues throughout the whole study.
Until now, no data have analysed the psychological effect of informed consent in critically ill patients. We could imagine, however, that the informed consent 'per se' could enhance the anxiety in patients that are already in a stressful environment and in a critical situation [6, 7]. Even if obtaining informed consent is in most cases an essential way of demonstrating respect for the patient's autonomy, it can lead to some unnecessary and even silly practices . In such situations, we could question, as did Dreyfuss, whether the informed consent is not more to protect the investigator than the patient .
Because informed consent in emergency research was not anticipated in previous regulations, the US Food and Drug Administration recommended in 1996 that research in some emergency circumstances might be conducted using an exception from informed consent (that is, a waiver of consent) . In the study conducted by Annane and colleagues, the waiver of consent probably contributed to the successful completion of the study and could allow one to improve medical knowledge in septic shock . The amendment of the UK's Medicines for Human Use Regulations 2004 recently came into force on 12 December 2006. The regulations now allow, also in the United Kingdom, unconscious patients in emergency situations to be enrolled in clinical trials without prior consent provided that this has been approved by the appropriate ethics committee [12, 13].
It is obvious that the risk assessment of the study must be included when considering a waiving of consent. Weijer proposed the concept of components analysis according to therapeutic or nontherapeutic procedures of the research . This way of evaluating the risks imputable to the research itself may help institutional review boards to better balance the potential benefit expected from the study and the real risks endorsed by the patients. McRae and colleagues even suggest that the components analysis would facilitate the approval of emergency research requiring a waiver of consent while protecting vulnerable research subjects .
As suggested by Huang and Hadian, we do not need more standards but some current standards have to be revisited because a number of critical care situations were not anticipated in these standards. Informed consent is a good example of such a standard procedure that should be reconsidered. Indeed, the usual informed-consent procedure is not as applicable as required or sufficient to warrant the respect of the patient autonomy in the critical care setting.
- Huang DT, Hadian M: Bench-to-bedside review: human subjects research – are more standards needed? Crit Care 2006, 10: 244. 10.1186/cc5114PubMed CentralView ArticlePubMedGoogle Scholar
- Lemaire F: The inability to consent in critical care research: emergency or impairment of cognitive function? Intensive Care Med 2006, 32: 1930-1932. 10.1007/s00134-006-0359-3View ArticlePubMedGoogle Scholar
- National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research: The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects in Research. Washington, DC: US Government Printing Office; 1979.Google Scholar
- Chenaud C, Merlani P, Luyasu S, Ricou B: Informed consent for research obtained during the intensive care unit stay. Crit Care 2006, 10: R170. 10.1186/cc5120PubMed CentralView ArticlePubMedGoogle Scholar
- Chenaud C, Merlani P, Ricou B: Informed consent for research in ICU obtained before ICU admission. Intensive Care Med 2006, 32: 1-6. 10.1007/s00134-005-0059-4View ArticleGoogle Scholar
- Szokol JW, Vender JS: Anxiety, delirium, and pain in the intensive care unit. Crit Care Clin 2001, 17: 821-842. 10.1016/S0749-0704(05)70182-2View ArticlePubMedGoogle Scholar
- Dreyfuss D: To consent or not to consent, that is (not) the (sole) question. 'And there is nothing new under the sun'. Kohelet (also known as Ecclesiastes), 1:9. Bible. Intensive Care Med 2004, 30: 180-182. 10.1007/s00134-003-2064-9View ArticlePubMedGoogle Scholar
- Truog RD: Will ethical requirements bring critical care research to a halt? Intensive Care Med 2005, 31: 338-344. 10.1007/s00134-004-2480-5View ArticlePubMedGoogle Scholar
- Dreyfuss D: Is it better to consent to an RCT or to care? Muetadeltaepsilonnu alphagammaalphanu ('nothing in excess'). Intensive Care Med 2005, 31: 345-355. 10.1007/s00134-004-2493-0View ArticlePubMedGoogle Scholar
- Department of health and human Services/Food and Drug Administration/office of Secretary: Protection of human subjects: informed consent and waiver of informed consent requirements in certain emergency research. Fed Reg 1996, 61: 51497-51533.Google Scholar
- Annane D, Outin H, Fisch C, Bellissant E: The effect of waiving consent on enrollment in a sepsis trial. Intensive Care Med 2004, 30: 321-324. 10.1007/s00134-003-2065-8View ArticlePubMedGoogle Scholar
- Medicines for Human Use (Clinical Trials) Amendment (No. 2) Regulations 2006. Statutory Instrument 2006 No 2984[http://www.opsi.gov.uk/si/si2006/20062984.htm]
- Shakur H, Roberts I, Barnetson L, Coats T: Clinical trials in emergency situations. BMJ 2007, 334: 165-166. 10.1136/bmj.39097.582130.80PubMed CentralView ArticlePubMedGoogle Scholar
- Weijer C: The ethical analysis of risk. J Law Med Ethics 2000, 28: 344-361. 10.1111/j.1748-720X.2000.tb00686.xView ArticlePubMedGoogle Scholar
- McRae AD, Ackroyd-Stolarz S, Weijer C: Risk in emergency research using a waiver of/exception from consent: implications of a structured approach for institutional review board review. Acad Emerg Med 2005, 12: 1104-1112. 10.1197/j.aem.2005.04.005View ArticlePubMedGoogle Scholar